Search / Trial NCT06615219

Intergroup Contact Intervention for Nursing Undergraduates to Improve Aging Stereotype

Launched by HUZHOU UNIVERSITY · Sep 23, 2024

Trial Information

Current as of December 21, 2024

Completed

Keywords

ClinConnect Summary

This research was designed as a pre-test-post-test randomized controlled experimental study. Nursing students from a university in Hangzhou, China served as the research subjects, who were randomly assigned to the experimental or control group. The control group received training in the regular course and was given compensatory intervention after the experiment, while the experimental group received intergroup contact training (the regular course combined with intergroup contact content). Such training was carried out in the forms of both individual and group interventions for a duration of...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • full-time undergraduate students enrolled in the nursing program
  • not yet enrolled in a geriatric nursing course
  • agreed to participate in this study and signed an informed consent form
  • Exclusion Criteria:
  • students in the nursing program pursuing a bachelor degree through a vocational-to-degree pathway
  • Students who have taken a break from their studies

Trial Officials

Meijuan Cao

Study Chair

Huzhou University

About Huzhou University

Huzhou University is a prominent educational and research institution located in Huzhou, China, dedicated to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, Huzhou University leverages its robust academic framework and interdisciplinary expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the global medical community. The university is committed to upholding the highest ethical standards in research, fostering collaborations with healthcare professionals, and translating scientific discoveries into practical applications that benefit society.

Locations

Hangzhou, Zhejiang, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0